Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients
Nephrology Dialysis Transplantation, 06/08/09
Park JT et al. - Study concludes that hyperuricaemia is common among peritoneal dialysis (PD) patients and is significantly associated with the rate of decline of residual renal function (RRF).
Methods- Study was conducted to investigate:
- the prevalence of hyperuricaemia and
- the relationship between UA and RRF in PD pts
- 134 PD pts who started dialysis between Jan 2000 and Dec 2005
- Timed urine collections were performed within 1 month of PD commencement and at 6-mo intervals thereafter
- The slope of decline of RRF over time was calculated by linear regression analysis of serial urinary urea and creatinine clearances for each patient
- Biochemical and clinical data at the time of initial urine collection were considered as baseline
- At baseline, 32.8% of the PD pts had hyperuricaemia; majority of them were diabetic
- Hypertensive pts had a higher UA level vs normotensive pts
- The overall reduction rate of RRF in hyperuricaemic pts was higher vs normouricaemic group
- Hyperuricaemia and history of DM showed a negative correlation with the reduction rate of RRF after adjusting for:
- demographic data, comorbid conditions,
- body mass index, baseline RRF and medications
Today in Gout and Hyperuricemia...keeping you current
Receive free subspecialty "5-minute updates" via email
The modern management of gout
Rheumatology, 10/08/09
Tophaceous gout: an unusual cause of multiple fractures
Scandinavian Journal of Rheumatology , 10/16/09
Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cells
Arthritis Research & Therapy, 10/12/09
Sponsor
Article Search
Sponsor


See Latest Articles


